查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1373932

補體標靶治療市場，按類型、按應用、給藥途徑、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Complement-Targeted Therapeutics Market, By Type, By Application, By Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 300 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年，補體標靶治療市場規模為 72.008 億美元，2023年至2030年CAGR為 10.5%。

補體標靶治療市場-市場動態

對罕見和具有挑戰性的疾病的有效治療的未滿足的醫療需求將推動市場需求

過去，對各種與補體系統相關的疾病，如PNH、非典型溶血性尿毒症症候群（aHUS）等，都缺乏了解和缺乏特效治療方法。依庫珠單抗和拉維珠單抗等補體標靶藥物的出現大幅改變了與這些疾病搏鬥的個人的前景，在曾經缺乏可行替代品的情況下提供了挽救生命的治療方法。這項成就促進了補體標靶藥物的研究和投資增加，不僅適用於罕見疾病，也適用於自體免疫和發炎性疾病的更廣泛應用。這一發展有望改善患者的治療效果和提高生活品質。

補體標靶治療市場 - 關鍵見解

根據研究分析師提供的分析，在2023年至2030年的預測期內，全球補體標靶治療市場的年成長率預計約為 10.5%。

補體標靶治療領域預計將經歷大幅成長，這主要是由於針對罕見和挑戰性疾病的有效治療的醫療需求不斷上升而未得到滿足。

依類型細分，2022年陣發性夜間血紅素尿症成為主要類別。

從應用細分來看，醫院藥局在2022年脫穎而出，成為領先類別。

從地理位置來看，北美在2022年成為主要收入來源。

補體標靶治療市場細分分析：

全球補體標靶治療市場圍繞著幾個關鍵維度構建，包括類型、應用、給藥途徑和區域。

在類型類別中，市場分為三個主要部分：陣發性夜間血紅蛋白尿症和非典型溶血性尿毒症（AHUS）。值得注意的是，陣發性夜間血紅素尿症領域在市場上佔據主導地位。對有效藥物的迫切需求是補體標靶療法市場的驅動力，特別關注解決陣發性夜間血紅素尿症（PNH）。 PNH 是一種罕見且可能危及生命的血液疾病，其特徵是溶血。依庫麗單抗等藥物透過減少溶血和提高患者的生活品質徹底改變了 PNH 治療，強調了這些藥物在控制病情方面的重要性。

補體標靶治療市場 - 地理洞察

從地理來看，該市場遍及北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。在這些地區，各國在塑造商業動態方面發揮著重要作用。

在多種因素的推動下，北美補體標靶治療市場呈現持續成長。首先，該地區的人口老化導致年齡相關疾病的發生率更高，包括年齡相關性黃斑部病變（AMD），補體標靶藥物對此具有重大前景。其次，人們對發性睡眠性血紅素尿症（PNH）和非典型溶血性尿毒症症候群（aHUS）等罕見補體相關疾病的認知不斷提高，增加了對專門治療的需求，進一步促進了市場擴張。

補體標靶治療市場-競爭格局：

補體標靶治療領域的競爭格局充滿活力與創新。成熟的實體歷來都佔據重要地位，這主要歸功於其旗艦藥物依庫珠單抗（Eculizumab）。然而，隨著包括中小企業在內的各類製藥公司透過開發補體標靶藥物並擴大產品組合進入這一領域，競爭加劇。這種激烈的競爭促進了新藥領域的研究和創新，增強了補體相關疾病的治療選擇。

目錄

第1章 補體標靶治療市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘錄
    • 依類型分類的補體標靶治療市場摘錄
    • 依應用分類的補體標靶治療市場摘錄
    • 依給藥途徑分類的補體標靶治療市場摘錄
    • 依國家分類的補體標靶治療市場摘錄
    • 依地區分類的補體標靶治療市場摘錄
  • 競爭洞察

第3章 補體標靶治療主要市場趨勢

  • 補體標靶治療市場促進因素
    • 市場促進因素的影響分析
  • 補體標靶治療市場的限制
    • 市場限制影響分析
  • 補體標靶治療市場機會
  • 補體標靶治療市場未來趨勢

第4章 補體標靶治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 補體標靶治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 補體標靶治療市場格局

  • 2022年補體標靶治療市佔率分析
  • 細分資料：按主要製造商
    • 既有參與者分析
    • 新興參與者分析

第7章 補體標靶治療市場 - 依類型

  • 概述
    • 依類型分類的細分市場佔有率分析
    • 陣發性睡眠性血紅素尿
    • 非典型溶血性尿毒症候群（AHUS）

第8章 補體標靶治療市場 -依應用

  • 概述
    • 依應用的細分市場佔有率分析
    • 醫院藥房
    • 零售藥局
    • 網路藥局

第9章 補體標靶治療市場 - 依給藥途徑

  • 概述
    • 依給藥途徑分類的細分市佔率分析
    • 靜脈注射
    • 口服或皮下形式

第10章 補體標靶治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美補體標靶療法主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依類型）
    • 北美市場規模和預測（依應用）
    • 北美市場規模與預測（依管理途徑）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲補體標靶療法主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模與預測（依類型）
    • 歐洲市場規模和預測（依應用）
    • 歐洲市場規模與預測（依管理途徑）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區（APAC）
    • 概述
    • 亞太地區補體標靶療法主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模與預測（依類型）
    • 亞太地區市場規模與預測（依應用）
    • 亞太地區市場規模與預測（依管理途徑）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲補體標靶療法主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（依類型）
    • 拉丁美洲市場規模與預測（依應用）
    • 拉丁美洲市場規模與預測（依管理途徑）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲補體標靶療法主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依類型）
    • 中東和非洲市場規模及預測（依應用）
    • 中東和非洲市場規模及預測（依管理途徑）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第11章 主要供應商分析 - 補體標靶治療產業

  • 競爭儀表板
  • 公司簡介
    • Alexion Pharmaceuticals
    • Regeneron Pharmaceuticals
    • Apellis Pharmaceuticals
    • Ra Pharmaceuticals
    • Omeros Corporation
    • Achillion Pharmaceuticals
    • Idera Pharmaceuticals
    • Novartis
    • Janssen Pharmaceuticals
    • Biogen
    • Genentech
    • Amgen
    • CSL Behring
    • Alnylam Pharmaceuticals
    • Argenx

第12章 360 度分析師視角

第13章 附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1809

REPORT HIGHLIGHT

Complement-targeted Therapeutics Market size was valued at USD 7,200.8 Million in 2022, expanding at a CAGR of 10.5% from 2023 to 2030.

Complement-targeted medications represent a category of medical treatments designed to modulate the complement system, a pivotal component of the immune system. This system plays a dual role in safeguarding the body against infections while maintaining tissue equilibrium. However, dysregulation can lead to autoimmune disorders, inflammatory conditions, and tissue damage. Complement-targeted medications aim to restore immunological balance by either inhibiting or enhancing specific complement components. They hold the potential to address a diverse array of conditions, ranging from rare hereditary diseases like paroxysmal nocturnal hemoglobinuria (PNH) to more common issues such as age-related macular degeneration (AMD). These therapies mark a promising frontier in the realm of precision medicine.

Complement-targeted Therapeutics Market- Market Dynamics

Unmet medical need for effective treatments for rare and challenging diseases to propel market demand

In the past, various diseases related to the complement system, such as PNH and atypical hemolytic uremic syndrome (aHUS), were characterized by a lack of understanding and a shortage of specific treatments. The advent of complement-targeted medications like eculizumab and ravulizumab has dramatically transformed the outlook for individuals grappling with these conditions, offering life-saving therapies in situations where viable alternatives were once scarce. This accomplishment has catalyzed increased research and investment in complement-targeted drugs, not only for rare diseases but also for broader applications in autoimmune and inflammatory disorders. This development holds the promise of improved patient outcomes and a better quality of life.

Complement-targeted Therapeutics Market- Key Insights

According to the analysis provided by our research analyst, the global market for Complement-targeted Therapeutics is poised to witness an annual growth rate of approximately 10.5% throughout the forecast period spanning from 2023 to 2030.

The Complement-targeted Therapeutics sector is anticipated to experience substantial growth, primarily driven by the escalating unmet medical demands for effective treatments aimed at rare and challenging diseases.

When considering the segmentation by Type, the year 2022 witnessed Paroxysmal Nocturnal Haemoglobinuria as the dominant category.

In terms of Application segmentation, Hospital Pharmacies stood out as the leading category in 2022.

Geographically, North America emerged as the primary revenue generator in the year 2022.

Complement-targeted Therapeutics Market- Segmentation Analysis:

The Global Complement-targeted Therapeutics Market is structured around several key dimensions, including Type, Application, Route of Administration, and Region.

Within the Type category, the market is classified into three primary segments: Paroxysmal Nocturnal Haemoglobinuria and Atypical Haemolytic Uraemic Syndrome (AHUS). Notably, the Paroxysmal Nocturnal Haemoglobinuria sector assumes dominance in the market. The critical demand for effective medications is a driving force in the market for complement-targeted therapeutics, with a specific focus on addressing Paroxysmal Nocturnal Hemoglobinuria (PNH). PNH is a rare and potentially life-threatening blood disorder characterized by hemolysis. Medications like eculizumab have revolutionized PNH treatment by reducing hemolysis and enhancing the quality of life for patients, underscoring the significance of these drugs in managing the condition.

Complement-targeted Therapeutics Market- Geographical Insights

From a geographical standpoint, this market extends across regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Within these regions, individual countries play a significant role in shaping business dynamics.

The market for complement-targeted therapies in North America has demonstrated continuous growth, driven by a multitude of factors. Firstly, the region's aging population contributes to a higher incidence of age-related conditions, including age-related macular degeneration (AMD), for which complement-targeted medications hold significant promise. Secondly, the increasing awareness of rare complement-related disorders such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) has heightened the demand for specialized treatments, further fostering market expansion.

Complement-targeted Therapeutics Market- Competitive Landscape:

The competitive landscape in the field of complement-targeted therapies is marked by dynamism and innovation. Established entities have historically held prominent positions, primarily due to their flagship drug Soliris (eculizumab). Nevertheless, as a diverse range of pharmaceutical companies, including both small and medium-sized enterprises, enter the arena by developing complement-targeted medications and expanding their portfolios, competition intensifies. This heightened competition fosters research and innovation in the realm of new medications, consequently enhancing treatment options for complement-related disorders.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET KEY PLAYERS

  • Alexion Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Apellis Pharmaceuticals
  • Ra Pharmaceuticals
  • Omeros Corporation
  • Achillion Pharmaceuticals
  • Idera Pharmaceuticals
  • Novartis
  • Janssen Pharmaceuticals
  • Biogen
  • Genentech
  • Amgen
  • CSL Behring
  • Alnylam Pharmaceuticals
  • Argenx

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET, BY TYPE

  • Paroxysmal Nocturnal Haemoglobinuria
  • Atypical Haemolytic Uraemic Syndrome (AHUS)

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET, BY APPLICATION

  • Hospital Pharmacies
  • Retail Pharamacies
  • Online Pharmacies

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION

  • Intravenously
  • oral or subcutaneous forms

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Complement-targeted Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Complement-targeted Therapeutics Market Snippet by Type
    • 2.1.2. Complement-targeted Therapeutics Market Snippet by Application
    • 2.1.3. Complement-targeted Therapeutics Market Snippet by Route of Administration
    • 2.1.4. Complement-targeted Therapeutics Market Snippet by Country
    • 2.1.5. Complement-targeted Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Complement-targeted Therapeutics Key Market Trends

  • 3.1. Complement-targeted Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Complement-targeted Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Complement-targeted Therapeutics Market Opportunities
  • 3.4. Complement-targeted Therapeutics Market Future Trends

4. Complement-targeted Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Complement-targeted Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Complement-targeted Therapeutics Market Landscape

  • 6.1. Complement-targeted Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Complement-targeted Therapeutics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Paroxysmal Nocturnal Haemoglobinuria
    • 7.1.3. Atypical Haemolytic Uraemic Syndrome (AHUS)

8. Complement-targeted Therapeutics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hospital Pharmacies
    • 8.1.3. Retail Pharamacies
    • 8.1.4. Online Pharmacies

9. Complement-targeted Therapeutics Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 9.1.2. Intravenously
    • 9.1.3. oral or subcutaneous forms

10. Complement-targeted Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Complement-targeted Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Complement-targeted Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Complement-targeted Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Complement-targeted Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Complement-targeted Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Complement-targeted Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Alexion Pharmaceuticals
    • 11.2.2. Regeneron Pharmaceuticals
    • 11.2.3. Apellis Pharmaceuticals
    • 11.2.4. Ra Pharmaceuticals
    • 11.2.5. Omeros Corporation
    • 11.2.6. Achillion Pharmaceuticals
    • 11.2.7. Idera Pharmaceuticals
    • 11.2.8. Novartis
    • 11.2.9. Janssen Pharmaceuticals
    • 11.2.10. Biogen
    • 11.2.11. Genentech
    • 11.2.12. Amgen
    • 11.2.13. CSL Behring
    • 11.2.14. Alnylam Pharmaceuticals
    • 11.2.15. Argenx

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Complement-targeted Therapeutics Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Complement-targeted Therapeutics Market, by Type 2018-2030 (USD Million)
  • TABLE Complement-targeted Therapeutics Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Complement-targeted Therapeutics Market, by Application 2018-2030 (USD Million)
  • TABLE Complement-targeted Therapeutics Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Complement-targeted Therapeutics Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Complement-targeted Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Complement-targeted Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)